期刊文献+

缺碘地区甲状腺肿演变模式的探讨 被引量:1

Investigation of Succession Model for Goiter in Iodine Deficiency Area
原文传递
导出
摘要 目的探讨缺碘地区结节性甲状腺肿继发甲状腺功能亢进及甲状腺癌的演变模式。方法从原白求恩医科大学第三临床医院1980年1月至1994年12月期间切除的216例缺碘地区甲状腺肿患者标本中,按Hedley法以流式细胞仪筛选出24例异倍体标本,再将同一部位的石蜡包埋组织块进行增殖细胞核抗原(PCNA)、层黏蛋白(LN)、第Ⅷ因子相关抗原(FⅧ-RAg)及p53免疫组化染色,观察甲状腺滤泡增殖活性、间质变化及血管新生情况。结果 24例异倍体病例PCNA染色,其标记指数(PCNA-LI)与细胞增殖指数(PI)一致,均呈现高值。不规则的非滤泡状实质性结构、小滤泡以及含泡状大滤泡的多层壁中,PCNA阳性细胞丰富。LN染色发现具有强增殖能力PCNA阳性细胞突破基底膜,形成坏死病灶。第Ⅷ因子相关抗原染色与LN染色结果相结合,发现滤泡上皮增殖明显的部位,血管新生与间质增殖也加剧,为上皮细胞的增殖提供营养和优越的环境。结论甲状腺滤泡上皮增殖、间质增生及血管新生均参与结节形成及甲状腺功能亢进的发生,相应区域应视为癌前病变,提示了缺碘地区甲状腺肿的演变模式。 Objective To investigate the succession model for hyperthyroidism and thyroid carcinoma secondary to nodular goiter in iodine deficiency area.Methods A total of 216 specimens of goiter patients from iodine deficiency area were collected in the former 3rd hospital of Norman Bethune Medical College from January 1980 to December 1994.Twenty-four heteroploid samples were selected by the method of Hedley with Flow cytometry(FCM) analysis.Paraffin-embedded tissues from the same position were used to perform immunohistochemical staining for proliferating cell nuclear antigen(PCNA),laminin(LN),factor Ⅷ related antigen(FⅧ-RAg),and p53.The proliferative activity,stroma change,and angiogenesis were observed.Results PCNA label index(PCNA-LI) and proliferation index(PI) consistent in 24 heteroploid samples with PCNA staining were significantly higher value.PCNA positive cells were mainly distributed over non-follicular parenchymatous structures,small follicles,and multilayered structures with large bubbly follicles.Destroyed basement membrane and necrosis were found by LN staining in PCNA positive position with vigorous reproductive capacity.Combining FⅧ-RAg staining with LN staining,interstitial proliferation and angiogenesis were obvious in follicular epithelial cells with vigorous reproductive capacity,providing nutrition and superior environment for them.Conclusions The reproduction of thyroid follicular epithelial cells,interstitial proliferation,and angiogenesis are all involved in tuberosis and hyperthyroidism,forming precancerous lesion,which suggest the succession model of goiter in iodine deficiency area.
出处 《中国普外基础与临床杂志》 CAS 2011年第8期809-814,共6页 Chinese Journal of Bases and Clinics In General Surgery
基金 吉林省自然科学基金(项目编号:201015176)~~
关键词 结节性甲状腺肿 甲状腺癌 甲状腺功能亢进症 增殖细胞核抗原 免疫组织化学 血管新生 Nodular goiter Thyroid carcinoma Hyperthyroidism Proliferating cell nuclear antigen Immunohistochemistry Angiogenesis
  • 相关文献

参考文献27

  • 1张德恒,孙辉,崔俊生,陈瑞新,金仲田,白日星.长期补碘后甲状腺疾病的变迁[J].中国实用外科杂志,1998,18(5):277-278. 被引量:22
  • 2Ronald A.D, RicardoVl., PhilippUH, etal. Pathology and Genetics nf Tumors of Endocrine Organs: WHO Classifica lion of Tumors [M]. IARC Press, Lyon: 2004: 51-91.
  • 3Kreicbergs A, Brostrom LA, Cewrien G, et al. Cellular DNA content in human osteosareoma: aspects on diagnosis and prognosis [J]. Cancer, 1982, 50(11): 24176-2481.
  • 4De BB. Mclean E, Andersson M, et al. Iodine deficiency in 2007: global progress since 2003 [J]. Food Nutr Bull, 2008, 29(3): 195- 202.
  • 5孙团起,边建超,朱晓丽,李端树,王卓颖,吴毅.甲状腺乳头状癌组织中线粒体DNA含量的变化[J].复旦学报(医学版),2008,35(5):635-640. 被引量:4
  • 6Laytragoon- Lewin N, Chen F, CastroJ, etal. DNA content anti methylation of p16, DAPK and rassfla gene in turnout and distant, normal mucosal tissue of head and neck squa mous cell carcinoma patients [J]. Anticancer Res, 2010, 30 (11): 4643 4648.
  • 7Nguyen HG, Ravid K. Polyploidy: mechanisms and cancer promotion in hernatopoietic and other cells[J]. Adv Exp Mcd Biol, 2010, 676:105 -122.
  • 8辛波,肖光,张德恒,盖宝东.长期补碘后地方性甲状腺肿246例流式细胞分析[J].中国实用外科杂志,2003,23(3):148-150. 被引量:9
  • 9Lu C, Mishra A, Zhu YJ, et al. Genornic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma [J]. AmJ Cancer Res. 2011, 1(1): 1-13.
  • 10Kim HY, Park WY, KE LE, etal. Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma [J].J Cancer Res Ther, 2010, 6(4):452- 457.

二级参考文献73

  • 1曹慧仁,张元鑫,张红卫.从石蜡包埋组织高效提取RNA的优化及Shh的RT-PCR检测[J].山东大学学报(理学版),2004,39(4):101-103. 被引量:4
  • 2白耀.甲状腺恶性肿瘤诊断和治疗的热点讨论[J].中华内分泌代谢杂志,2004,20(4):283-286. 被引量:19
  • 3景红梅,克晓燕,董菲,高子芬,周晓鸽.石蜡包埋组织提取RNA检测API2-MALT1融合基因的研究[J].北京医学,2006,28(3):129-131. 被引量:7
  • 4Krokan H E, Otterlei M, Nilsen H, et al. Properties and functions of human uracil-DNA glycosylase from the UNG gene.Prog Nucleic Acid Res Mol Biol, 2001, 68:365-386
  • 5Dianova I I, Bohr V A, Dianov G L. Interaction of human AP endonuclease 1 with flap endonuelease 1 and proliferating cell nuclear antigen involved in long patch base excision repair.Biochemistry, 2001, 40:12639-12644
  • 6Fan J S, Otterlei M, Wong H K et al. XRCC1 co localizes and physically interacts with PCNA. Nucleic Acids Research, 2004,32(7):2193-2201
  • 7Haracska L, Unk I, Johnson R E, et al. Stimulation of DNA synthesis activity of human DNA polymerase κby PCNA. Molecular and Cellular Biology, 2002, 22(3): 784-791
  • 8Haracska L, Johnson R E, Unk I, et al. Physical and functional interactions of human DNA polymerase η with PCNA. Molecular and Cellular Biology, 2001, 21(21): 7199-7206
  • 9Kannouche P L, Wing J, Lehmann A R. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: A possible mechanism for the polymerase switch in response to DNA dam age. Mol Cell, May 21, 2004, 14(4): 491-500
  • 10Israels E D, G. Israels L. The cell cycle. Fundamentals of Cancer Medicine, 2001, 19:88-91

共引文献106

同被引文献28

  • 1赏金标,王可敬,张海,刘爱华,郭良,葛明华.甲状腺乳头状癌再次手术临床分析[J].中华普通外科杂志,2005,20(2):123-123. 被引量:19
  • 2杨英,付士波,李修义.切尔诺贝利核事故与甲状腺癌[J].中华放射医学与防护杂志,2007,27(4):413-415. 被引量:9
  • 3Deveci MS, Deveci G, LiVolsi VA, Gupta PK, Baloch ZW. Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination: effect on patient management[J]. Diagn Cytopathol, 2007, 35(9): 579-583.
  • 4Ito Y, Miyauchi A, Inoue B, et al. An observational trial for papillary thyroid $icrocarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1): 28-35.
  • 5Wei X, Li Y, Zhang S, Gao M. Prediction of thyroid extracapsular extension with cervical lymph node metastases (ECE-LN) by CEUS and BRAF expression in papillary thyroid carcinoma[J]. Tumour Biol, 2014, 35(9): 8559-64.
  • 6Benbassat C, Hirsch D, Robenshtok E, Bachar G. [Two decades of progress in the diagnosis and treatment of differentiated thyroid cancer][J], narefuah, 2014, 153(8): 482-6, 496.
  • 7WOOLNER LB, BEAHRS OH, BLACK BM, McCONAHEY WM, KEATING FR Jr. Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period[J]. Am J Surg, 1961, 102: 354-87.
  • 8Godbert Y, Henriques-Figueiredo B, Cazeau AL, et al. h papillary thyroid microcarcinoma revealed by a single bone lesion with no poor prognostic factors[J].Case llep Endocrinol, 2013, 20 (13) : 719-304.
  • 9Wu LS, Milan SA. Management of microcarcinomas (papillary and medullary) of the thyroid[J]. Curt 0pin Oncol, 2013, 25(1): 27-32.
  • 10Hay IO, Hutchinson ME, Gonzalez-Losada Tet al. Papillary thyroid microcarcin:astudy Of 900 cases observed in a 60-year period[J]. Surgery, 2008, 14(6):980-987.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部